CRAIG R SMITH
CIK 938742 · last filed 2020-03-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.63M
Companies
4
Total Filings
33
Lifetime Open-Market Net
$94.7K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ADX | Director | 54,469 | $25.98 | $1.42M | $231.7K | 12 | 2020-03-16 |
| PEO | Director | 7,812 | $27.45 | $214.4K | -$135.5K | 2 | 2018-05-31 |
| Assertio Therapeutics, Inc (DEPO) Delisted | Director | — | — | — | $0 | 6 | 2012-12-06 |
| LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Director | 0 | $6.22 | $0 | -$1.5K | 4 | 2009-02-27 |
Recent Filings · Page 2 of 4
33 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-03-21 | — | Grant (A) | +400 | $0 | |
| 2011-12-22 | Assertio Therapeutics, Inc (DEPO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-03-23 | ADX | Grant (A) | +750 | $0 | EDGAR |
| 2011-03-23 | — | Grant (A) | +400 | $0 | |
| 2010-12-13 | Assertio Therapeutics, Inc (DEPO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-03-24 | ADX | Mixed | +781 | $327 | EDGAR |
| 2010-03-24 | — | Mixed | +423 | $547 | |
| 2009-12-08 | Assertio Therapeutics, Inc (DEPO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-04-15 | — | Buy (P) | +2,000 | $38.2K | |
| 2009-03-20 | — | Mixed | +469 | $1.2K |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.